more reasons to advocate for judicious use of PPIs

See updated FDA information concerning the association of C. difficile and PPIs

You'll see more reasons to advocate for judicious use of PPIs.

PPIs (omeprazole, etc) are already associated with a higher risk of pneumonia...Clostridium difficile diarrhea...and fractures. They might also decrease the ability of bisphosphonates to prevent fractures.

Now new Rx labeling will warn that long-term use of PPIs may cause hypomagnesemia...possibly by decreasing magnesium absorption.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote